Professor Matthew Cooper (NHMRC Aust)

Matthew Cooper

Professor Matthew Cooper’s research focuses on the rational design and development of novel antibiotics and anti-virals active against drug-resistant pathogens. In particular, Prof. Cooper is interested in hospital-acquired infections, such as the strain of golden staph known as MRSA, which is resistant to most antibiotic treatments. His group is involved in the development of specific tags to overcome bacterial resistance and deliver these antibiotics to the target. In addition, Prof. Cooper’s research involves the discovery and exploitation of novel biophysical methods for characterising molecular pathways involved in disease, and rapid in vitro and ex vivo diagnosis of disease.

Publications

More information

On this site